Educational Sessions

 

Monday, March 27th

09:00-10:30 - Morgiou

E1: Transplant in non-hematological disorders

Chairs:                  John Snowden, UK & Francesco Lanza, Italy

09:00-09:30         HSCT for multiple sclerosis and other autoimmune diseases of the nervous system: Harold Atkins, Canada

09:30-10:00         High-dose chemotherapy and autologous stem cell transplantation in breast cancer: a never ending story?
                              Antony Goncalves, France

10:00-10:30         Stem cell therapy in Rheumatic diseases: Dominique Farge-Bancel, France

 

11:00-12:30 - Auditorium

E2: Transplant in myeloma

Chairs:                  Mohamad Mohty, France & William Bensinger, USA

11:00-11:30         The role of upfront auto transplantation in myeloma: William Bensinger, USA

11:30-12:00         Double autotransplant: Jean-Luc Harousseau, France

12:00-12:30         Autotransplantation in elderly patients with multiple myeloma: Joan Bladé, Spain

 

11:00-12:30 - Amphithéâtre Callelongue

E3: Allogeneic transplantation and gene therapy of inherited disorders

Chairs:                  Isabelle Thuret, France & Simone Cesaro, Italy

11:00-11:30         Primary Immunodeficiencies: Andrew Gennery, UK

11:30-12:00         Fanconi anemia and other inherited marrow failure disorders: Carlo Dufour, Italy

12:00-12:30         SCID: Marina Cavazzana, France

 

14:30-16:00 - Auditorium

E4: Transplant in the treatment algorithm of myeloid disorders

Chairs:                  Norbert Vey, France & Jorge Sierra, Spain

14:30-15:00         Transplant in the treatment algorithm of AML: Jorge Sierra, Spain

15:00-15:30         MDS: Uwe Platzbecker, Germany

15:30-16:00         MPN: Nicolaus Kröger, Germany

 

14:30-16:00 - Les Goudes 1

E5: Transplant in the treatment algorithm of lymphoma

Chairs:                  Noël Milpied, France & Silvia Montoto, UK

14:30-15:00         Hematopoietic cell transplantation for T-cell lymphomas: when is the right time to offer it?
                              Mohamed Kharfan-Dabaja, USA

15:00-15:30         Mantle cell lymphoma: Steve LeGouill, France

15:30-16:00         Rare lymphomas: Peter Dreger, Germany

 

Tuesday, March 28th

09:00-10:30 - Hall 2

E6: Management of rare early post-transplant complications

Chair:                   Rafael Duarte, Spain

09:00-09:30         Neurological disorders: Rémy Duléry, France, France

09:30-10:00         TMA: Paul Coppo, France

10:00-10:30         Capillary leak syndrome: Enric Carreras, Spain

 

09:00-10:30 - Auditorium

E7: GVHD

Chairs:                  Pierre-Simon Rohrlich, France & Sophie Paczesny, USA

09:00-09:30         Current issues in the management of acute GVHD: Gerard Socié, France

09:30-10:00         Therapy of chronic GVHD: Dawn of targeted intervention: Madan Jagasia, USA

10:00-10:30         Biomarkers to guide GVHD prevention and preemptive therapy: Jan Storek, Canada

               

11:00-12:30 - Hall 2

E8: Post-transplant therapies for relapse prevention

Chairs:                  Ibrahim Yakoub-Agha, France & Arnon Nagler, Israel

11:00-11:30         Prophylactic and pre-emptive DLI: Christoph Schmid, Germany

11:30-12:00         FLT3-inhibitors - prior and post-transplant: Richard Schlenk, Germany

12:00-12:30         Hypomethylating agents: Charles Craddock, UK

 

11:00-12:30 - Les Goudes 1

E9: Some transplant challenges across the world

Chairs:                  Mahmoud Al-Jurf, Saudi Arabia & Dietger Niederwiesser, Germany

11:00-11:30         HSCT challenges in the Eastern-Mediterranean and Middle-East region: Amir Ali Hamidieh, Iran

11:30-12:00         Setting up a new transplantation program: Mickey Koh, UK/Singapore

12:00-12:30         Emerging infectious threats: Zika virus, Chikungunya, Dengue etc: Jan Styczynski, Poland

 

Wednesday, March 29th

09:00-10:30 - Les Goudes 2

E10: Late post-transplant complications

Chairs:                  Bipin Savani, USA & Rafael Duarte, Spain

09:00-09:30         Metabolic syndrome in adults transplanted during childhood: Gérard Michel, France

09:30-10:00         Revaccination post-transplant: Eolia Brissot, France

10:00-10:30         Physical Symptoms: Bipin Savani, USA

 

09:00-10:30 - Endoume 3

E11: Criteria for donor choice: HLA & beyond

Chairs:                  Christophe Picard, France & Alejandro Madrigal, UK

09:00-09:30         NGS in HLA-typing: are all mismatches equivalent? Jean Marie Tiercy, Switzerland

09:30-10:00         Permissive mismatches: Katharina Fleischhauer, Germany

10:00-10:30         The non-conventional MHC-I and MICA gene is critically involved in GVHD: Seiamak Bahram, France

                  

11:00-12:30 - Les Goudes 2

E12: Pre and post-transplant interventions

Chairs:                  Olivier Hermine, France & Hans-Jochem Kolb, Germany

11:00-11:30         Novel antibodies: Ali Bazarbachi, Lebanon

11:30-12:00         Immune checkpoint inhibitors: Ali Bazarbachi, Lebanon

12:00-12:30         Anti-complement drug and allogeneic HSCT: Régis Peffault de Latour, France